2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and so...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | European Thyroid Journal |
Subjects: | |
Online Access: | https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xml |
_version_ | 1797955321715490816 |
---|---|
author | Furio Pacini Dagmar Fuhrer Rossella Elisei Daria Handkiewicz-Junak Sophie Leboulleux Markus Luster Martin Schlumberger Johannes W Smit |
author_facet | Furio Pacini Dagmar Fuhrer Rossella Elisei Daria Handkiewicz-Junak Sophie Leboulleux Markus Luster Martin Schlumberger Johannes W Smit |
author_sort | Furio Pacini |
collection | DOAJ |
description | Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and some low-risk pati ents. Since the last consensus on post-surgical use of RAI in DTC patients, new retr ospective data and results of prospective randomized trials have been published, w hich have allowed the development of a new European Thyroid Association (ETA) stateme nt for the indications of post-surgical RAI therapy in DTC. Questions about which pati ents are candidates for RAI therapy, which activities of RAI can be used, and which mod alities of pre-treatment patient preparation should be used are addressed in the present guidelines. |
first_indexed | 2024-04-10T23:32:21Z |
format | Article |
id | doaj.art-f5bc1da3cd3245e8a6fee2a1cab6f5da |
institution | Directory Open Access Journal |
issn | 2235-0802 |
language | English |
last_indexed | 2024-04-10T23:32:21Z |
publishDate | 2023-01-01 |
publisher | Bioscientifica |
record_format | Article |
series | European Thyroid Journal |
spelling | doaj.art-f5bc1da3cd3245e8a6fee2a1cab6f5da2023-01-12T05:46:01ZengBioscientificaEuropean Thyroid Journal2235-08022023-01-0111119https://doi.org/10.1530/ETJ-21-00462022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini0Dagmar Fuhrer1Rossella Elisei2Daria Handkiewicz-Junak3Sophie Leboulleux4Markus Luster5Martin Schlumberger6Johannes W Smit7Section of Endocrinology, University of Siena, Siena, ItalyDepartment of Endocrinology, Diabetes and Metabolism, West German Cancer Centre (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, GermanySection of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, ItalyDepartment of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, PolandGustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, FranceDepartment of Nuclear Medicine, University Hospital Marburg, Marburg, GermanyGustave Roussy Cancer Campus and University Paris-Saclay, Villejuif, Cedex, FranceRadboud University Medical Center, Nijmegen, NetherlandsModern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patients, controversy remains in intermediate-risk and some low-risk pati ents. Since the last consensus on post-surgical use of RAI in DTC patients, new retr ospective data and results of prospective randomized trials have been published, w hich have allowed the development of a new European Thyroid Association (ETA) stateme nt for the indications of post-surgical RAI therapy in DTC. Questions about which pati ents are candidates for RAI therapy, which activities of RAI can be used, and which mod alities of pre-treatment patient preparation should be used are addressed in the present guidelines.https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xmldifferentiated thyroid cancerradioiodinetreatmentindications |
spellingShingle | Furio Pacini Dagmar Fuhrer Rossella Elisei Daria Handkiewicz-Junak Sophie Leboulleux Markus Luster Martin Schlumberger Johannes W Smit 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? European Thyroid Journal differentiated thyroid cancer radioiodine treatment indications |
title | 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? |
title_full | 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? |
title_fullStr | 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? |
title_full_unstemmed | 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? |
title_short | 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? |
title_sort | 2022 eta consensus statement what are the indications for post surgical radioiodine therapy in differentiated thyroid cancer |
topic | differentiated thyroid cancer radioiodine treatment indications |
url | https://etj.bioscientifica.com/view/journals/etj/11/1/ETJ-21-0046.xml |
work_keys_str_mv | AT furiopacini 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT dagmarfuhrer 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT rossellaelisei 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT dariahandkiewiczjunak 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT sophieleboulleux 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT markusluster 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT martinschlumberger 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer AT johanneswsmit 2022etaconsensusstatementwhataretheindicationsforpostsurgicalradioiodinetherapyindifferentiatedthyroidcancer |